Boise State Center of Biomedical Research Excellence (COBRE) has been selected to receive the institute’s Phase 2 funding, which will sustain the momentum of Boise State’s biomedical research with another $10 million over five years.
Boise State Center of Biomedical Research Excellence (COBRE) has been selected to receive the institute’s Phase 2 funding, which will sustain the momentum of Boise State’s biomedical research with another $10 million over five years.